Sanovel Pharmaceutical develops and changes through its innovative approaches. In every project it undertakes, it does not deviate from the quality policy and, with its employees, aims to protect ethical values and to preserve continuity in its approach. In accordance with the purpose for which we were founded, we adopt a quality policy that includes the expectations of all our stakeholders and our responsibilities towards the public and the environment.
At Sanovel Pharmaceutical, the requirements concerned with data integrity apply equally to data in paper or electronic form. This approach encourages the reporting of potential errors openly. To create an effective working environment, the necessary data are transferred to all staff at Sanovel Pharmaceutical and the service providers.
In line with the Code of Federal Regulations Part 11 and the Eudralex Vol.4 Annex-11 guidelines, all laboratory devices are selected for the purpose of creating and protecting the data in a “correct, original, simultaneous, legible, qualifiable” form, and are configured according to current expectations. The systems are periodically checked and the requirements for modernisation or corrective/preventive action are evaluated.
Thanks to the "Scientific Data Management System (SDMS)" used in the laboratory, the scientific data produced are electronically controlled and confirmed, aggregated in a common database and stored in a secure environment to allow retrospective research. SDMS is a solution used to improve data flow, advance decision-making capabilities, shorten product time to market, ensure compliance with current regulations and increase the value of scientific data, which is vital at Sanovel Pharmaceuticals.
Our firm is a manufacturer of products for a healthy life which promises to: